tetano
Editor, Senior Moderator
Life (Basel)
. 2022 Jul 18;12(7):1072.
doi: 10.3390/life12071072.
ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
Michalis Christodoulou[SUP] 1 [/SUP], Fotini Iatridi[SUP] 1 [/SUP], George Chalkidis[SUP] 1 [/SUP], Georgios Lioulios[SUP] 1 [/SUP], Christina Nikolaidou[SUP] 2 [/SUP], Kostas Badis[SUP] 1 [/SUP], Asimina Fylaktou[SUP] 3 [/SUP], Aikaterini Papagianni[SUP] 1 [/SUP], Maria Stangou[SUP] 1 [/SUP]
Affiliations
Abstract
In the last two years, our world experienced one of the most devastating and fast-exploding pandemic, due to the wide spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The scientific community managed to develop effective vaccines, the main weapons to shield the immune system and protect people. Nevertheless, both SARS-CoV-2 infection and the vaccination against it have been associated with the stimulation of inflammatory cells such as T and B lymphocytes that results in a cytokine storm, endothelial inflammation and vascular injury, which can lead to different types of vasculitis. We present the first case of de novo MPO-ANCA-associated vasculitis, which developed shortly after SARS-CoV-2 vaccination, adequately responded to treatment, and subsequently relapsed after COVID-19 infection. With this case, we indicate an etiological connection between viral infection and disease development, as well as the possibility of a common immune mechanism between SARS-CoV-2 infection and vaccination, that can stimulate vascular events and lead to vasculitis. There have been several case reports of de novo vasculitis, affecting large, medium, or small vessels, following either infection or vaccination against COVID-19, during the pandemic outbreak. We summarize previous reports and also analyze proposed pathogenic mechanisms between SARS-CoV-2 and vasculitis.
Keywords: ANCA vasculitis; COVID-19 infection; glomerulonephritis; vaccination.
. 2022 Jul 18;12(7):1072.
doi: 10.3390/life12071072.
ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
Michalis Christodoulou[SUP] 1 [/SUP], Fotini Iatridi[SUP] 1 [/SUP], George Chalkidis[SUP] 1 [/SUP], Georgios Lioulios[SUP] 1 [/SUP], Christina Nikolaidou[SUP] 2 [/SUP], Kostas Badis[SUP] 1 [/SUP], Asimina Fylaktou[SUP] 3 [/SUP], Aikaterini Papagianni[SUP] 1 [/SUP], Maria Stangou[SUP] 1 [/SUP]
Affiliations
- PMID: 35888159
- DOI: 10.3390/life12071072
Abstract
In the last two years, our world experienced one of the most devastating and fast-exploding pandemic, due to the wide spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The scientific community managed to develop effective vaccines, the main weapons to shield the immune system and protect people. Nevertheless, both SARS-CoV-2 infection and the vaccination against it have been associated with the stimulation of inflammatory cells such as T and B lymphocytes that results in a cytokine storm, endothelial inflammation and vascular injury, which can lead to different types of vasculitis. We present the first case of de novo MPO-ANCA-associated vasculitis, which developed shortly after SARS-CoV-2 vaccination, adequately responded to treatment, and subsequently relapsed after COVID-19 infection. With this case, we indicate an etiological connection between viral infection and disease development, as well as the possibility of a common immune mechanism between SARS-CoV-2 infection and vaccination, that can stimulate vascular events and lead to vasculitis. There have been several case reports of de novo vasculitis, affecting large, medium, or small vessels, following either infection or vaccination against COVID-19, during the pandemic outbreak. We summarize previous reports and also analyze proposed pathogenic mechanisms between SARS-CoV-2 and vasculitis.
Keywords: ANCA vasculitis; COVID-19 infection; glomerulonephritis; vaccination.